Zaks Tal Zvi sold $593 of TEVA
Zaks Tal Zvi sold 17 shares of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) at $34.87 on 2026-08-05.
How this was made
The 30-second read
Why it matters
The newest fact is the director’s open-market sale details (17 shares at $34.8655, $592.71 total) and post-transaction holdings (73,247 shares).
Market read
Traders may note the insider sale for sentiment, but the disclosed transaction size is too small to be a standalone fundamental catalyst.
What to watch
Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; the filing provides no rationale or follow-on buying.
Background
The article is an SEC Form 4 insider transaction disclosure for TEVA, reported via SEC EDGAR.
Ticker impact
SEC Form 4 shows director Zaks Tal Zvi sold 17 shares of TEVA at $34.8655 on 2026-08-05, totaling $592.71.
Low likelihood of a sustained price move; any reaction would likely be brief and sentiment-driven.
The filing is a primary-source insider transaction, but the disclosed size ($592.71) is small relative to a large public issuer, and there is no accompanying corporate event or guidance change in the text.
Market effects
No sector read-through is provided; this is company-specific insider selling only.
None indicated.
None indicated.
Counterpoint
Because the sale is not tied to a disclosed 10b5-1 plan, some traders may interpret it as a signal, even if the dollar amount is small.
Key entities
- issuerTEVA
Teva Pharmaceutical Industries Ltd, the subject of the insider transaction filing.
- insiderZaks Tal Zvi
Director who sold 17 shares in an open-market transaction.
